ClinicalTrials.gg

Program

VRB-101

A development code.

Its studies are mostly in Obesity, led by Verdiva Bio Dev.

Furthest: phase 2, since Dec 4, 20253 company-led studies, 1 open or runningNext primary completion: Mar 2028 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Verdiva Bio Dev31 open or runningphase 2since Dec 4, 2025Dec 4, 2025Mar 2028phase 1 · NCT07628127

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Dec 4, 2025First study: phase 2 study in ObesityFirst studyNCT07281937 · 206 enrolled · United States
  2. Apr 2, 2026Phase 2 study in ObesityNCT07553299 · 8 enrolled · United States
  3. May 29, 2026Phase 1 study in ObesityNCT07628127 · 332 planned · Australia

Ahead

  1. Mar 2028Primary completion: phase 1 study in ObesityNCT07628127

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 3 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07628127Obesity · Australia1RecruitingMar 2028332
NCT07553299Obesity · United States2TerminatedSep 11, 20268
NCT07281937Obesity · United States2CompletedJul 23, 2026206

How it is read

Names in the registry

  • “VRB-101”, 3 entries

Codes read as this program: VRB101.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.
VRB-101 (Verdiva Bio Dev): development program | ClinicalTrials.gg